alexa Pharmacogenetics of Oral Antidiabetic Drugs

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Pharmacogenetics of Oral Antidiabetic Drugs
Oral antidiabetic drugs (OADs) are widely used to treat type 2 diabetes mellitus (T2DM). However, inherited difference is one of the major issues that affect OADs therapeutic efficacy. In the present paper, we performed a critical review on recent advances in genetic polymorphisms that influence OADs therapeutic efficacy and metabolism. Sulfonylureas (SUs), Meglitinides, Metformin and Thiazolidinediones (TZDs) will be discussed. Citation: Yin J, Guo Y, Huang Q, Sun H, Zhou H, et al. (2012) Pharmacogenetics of Oral Antidiabetic Drugs: Potential Clinical Application. Endocrinol Metabol Syndrome S5:003. doi: 10.4172/2161-1017.S5-003
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger